Clinical Trial Update: Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating vosaroxin with cytarabine vs placebo with cytarabine in patients with first relapsed or refractory acute myeloid leukemia has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Vosaroxin (vosaroxin)

Snippet

Sponsor: Sunesis Pharmaceuticals | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2017-05-09